Filing Details
- Accession Number:
- 0001161697-22-000399
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-19 17:02:54
- Reporting Period:
- 2022-08-18
- Accepted Time:
- 2022-08-19 17:02:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 929985 | J Patrick Mcenany | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-08-18 | 25,000 | $2.53 | 4,955,217 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-08-18 | 25,000 | $13.93 | 4,930,217 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-08-18 | 50,000 | $2.53 | 4,980,217 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-08-18 | 50,000 | $13.93 | 4,930,217 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-08-18 | 50,000 | $2.53 | 4,980,217 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-08-18 | 50,000 | $13.96 | 4,930,217 | No | 4 | S | Direct | |
| Common Stock,. Par Value $0.001 Per Share | Acquisiton | 2022-08-18 | 50,000 | $2.53 | 4,980,217 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-08-18 | 50,000 | $13.95 | 4,930,217 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-08-19 | 125,000 | $2.53 | 5,055,217 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-08-19 | 125,000 | $14.10 | 4,930,217 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Disposition | 2022-08-18 | 25,000 | $0.00 | 25,000 | $2.53 |
| Common Stock | Options to purchase common stock | Disposition | 2022-08-18 | 50,000 | $0.00 | 50,000 | $2.53 |
| Common Stock | Options to purchase common stock | Disposition | 2022-08-18 | 50,000 | $0.00 | 50,000 | $2.53 |
| Common Stock | Options to purchase common stock | Disposition | 2022-08-18 | 50,000 | $0.00 | 50,000 | $2.53 |
| Common Stock | Options to purchase common stock | Disposition | 2022-08-19 | 125,000 | $0.00 | 125,000 | $2.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,640,834 | 2022-12-30 | No | 4 | M | Direct | |
| 3,590,834 | 2022-12-30 | No | 4 | M | Direct | |
| 3,540,834 | 2022-12-30 | No | 4 | M | Direct | |
| 3,490,834 | 2022-12-30 | No | 4 | M | Direct | |
| 3,365,834 | 2022-12-30 | No | 4 | M | Direct |
Footnotes
- Shares were sold in various lots from $13.93 to $13.97 per share. The listed sales price represents a weighted average price for the shares sold.
- Shares were sold in various lots from $13.93 to $13.94 per share. The listed sales price represents a weighted average price for the shares sold.
- Shares were sold in various lots from $13.95 to $14.00 per share. The listed sales price represents a weighted average price for the shares sold.
- Shares were sold in various lots from $13.95 to $13.98 per share. The listed sales price represents a weighted average price for the shares sold.
- Shares were sold in various lots from $14.05 to $14.14 per share. The listed sales price represents a weighted average price for the shares sold.
- Shares were sold to cover the exercise price of options, tax withholding requirements (if applicable) and for personal reasons. The shares were not sold as a result of any agreement with the Company and Mr. McEnany remains an officer of the company.
- Options vested in three separate tranches beginning on December 30, 2016.
Billionaire Hedge Funds
